Stem cell news is always burbling up, sometimes right there in front of us on the web and other times via networks of people. Astellas news. Some may remember there used to be this pioneering stem cell biotech called ACT, which then became Ocata, and finally was acquired by the big company Astellas. One of …
Stem cell news bites: Astellas trial, cystic fibrosis claim, a few cool papers Read More »
Attorney Richard Jaffe, who has been an advocate for clinics to have the right to sell and patient to buy unproven therapies such as the stem cells sold by clinics and unproven cancer therapies, just did a kind of shocking u-turn on a specific point. Jaffe and I have very different philosophical views of the …
Attorney Jaffe, fan of less oversight, still clobbers Florida stem cell clinic firm Read More »
For years I’ve been working on an educational outreach program that I call SCOPE, for stem cell outreach program for education that translates a concise stem cell white paper I wrote with key basic and clinical stem cell information into as many languages as possible. Now with the addition of Czech with thanks to translator …
Stem Cells Not Lost in Translation Project: Now up to 33 languages with Czech Read More »
For me there was a sense of “finally” when just under 3 months ago the FDA filed suits via the DOJ against 2 stem cell clinic firms, U.S. Stem Cell (and its affiliate U.S. Stem Cell Clinic, collectively referred to here as USRM) and California Stem Cell Treatment Center/Cell Surgical Network (collectively referred to here as …
As 2 FDA stem cell clinic suits slowly unfold, more action needed now Read More »